Qianjun Chen

机构：Guangzhou University of Chinese Medicine, Central China Normal University, Ji Hua Laboratory, Key Laboratory of Guangdong Province, Guangdong Provincial Hospital of Traditional Chinese Medicine, Shenzhen Luohu People's Hospital, Shenzhen Third People’s Hospital, Clausthal University of Technology, Hubei University · ORCID：0000-0002-9072-4197

发表论文 65 篇 · 总被引 1402 次 · h-index 16

代表论文

• International experience of carbon neutrality and prospects of key technologies: Lessons for China (2023 · Petroleum Science · 被引 100)
• Entinostat, a class I selective histone deacetylase inhibitor, plus exemestane for Chinese patients with hormone receptor-positive advanced breast cancer: A multicenter, randomized, double-blind, placebo-controlled, phase 3 trial (2023 · Acta Pharmaceutica Sinica B · 被引 60)
• Prevotella copri exhausts intrinsic indole-3-pyruvic acid in the host to promote breast cancer progression: inactivation of AMPK via UHRF1-mediated negative regulation (2024 · Gut Microbes · 被引 51)
• Strategies toward carbon neutrality: comparative analysis of China, USA, and Germany (2025 · Carbon Neutral Systems · 被引 34)
• Mechanisms in surface coloring of titanium alloy induced by picosecond laser (2022 · Journal of Manufacturing Processes · 被引 29)
• A supervised data augmentation strategy based on random combinations of key features (2023 · Information Sciences · 被引 24)